Jiangsu, China

Ling Wu



Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations by Inventor Ling Wu from Jiangsu, China

Introduction

Ling Wu is an accomplished inventor based in Jiangsu, China, known for her significant contributions to the field of pharmaceutical compounds. With a total of four patents under her name, she has made strides in developing innovative solutions for treating serious health conditions, including cancer and neurodegenerative diseases.

Latest Patents

Among her latest patents, the first one, titled "Substituted Tricyclic Heterocyclic Compounds and Use Thereof," details a substituted tricyclic heterocyclic compound that can be used in various pharmaceutical applications. This compound is crucial for addressing disorders related to cancer and neurodegenerative diseases, showcasing her commitment to advancing medical treatments.

The second patent, "Pharmaceutical Composition Containing Docetaxel-Cyclodextrin Inclusion Complex and its Preparing Process," describes a novel method for creating a docetaxel inclusion complex that has improved water solubility and stability. This innovation not only enhances the effectiveness of docetaxel but also outlines a detailed process for its preparation, reflecting Wu's expertise in pharmaceutical chemistry.

Career Highlights

Ling Wu has worked with reputable companies such as Hainan Hdeton Science and Technology Co., Ltd. and LifeArc, where her focus has been on drug development and innovation. Her career has been marked by a dedication to finding effective solutions for health issues, which is evident in her patent filings.

Collaborations

Throughout her career, Wu has collaborated with notable colleagues, including Yong Ren and Jianfeng Gao. These partnerships have helped her to further her research initiatives and enhance her contributions to the field of pharmaceuticals.

Conclusion

Ling Wu's inventive work in developing tricyclic heterocyclic compounds and docetaxel inclusion complexes marks her as a significant figure in the pharmaceutical industry. Her innovations are paving the way for new treatments that have the potential to improve the quality of life for patients battling serious diseases. With continued research and development, she is likely to make even more impactful contributions in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…